BMS clinical trial educational resource [clinicaltrials_resource:ecfe78d31cdc78071484d9e34e103653]
clinicaltrials:NCT00065507Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant [clinicaltrials:NCT00114777]clinicaltrials:NCT00123474clinicaltrials:NCT00123487clinicaltrials:NCT00162123clinicaltrials:NCT00254293Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression (BENEFIT) [clinicaltrials:NCT00256750]clinicaltrials:NCT00306202clinicaltrials:NCT00324155clinicaltrials:NCT00364793Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection [clinicaltrials:NCT00388674]A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids [clinicaltrials:NCT00402168]clinicaltrials:NCT00423891A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664) [clinicaltrials:NCT00437437]clinicaltrials:NCT00439270clinicaltrials:NCT00452673clinicaltrials:NCT00481247clinicaltrials:NCT00496769clinicaltrials:NCT00529763clinicaltrials:NCT00560391Phase I/II Combination With Irinotecan- Erbitux [clinicaltrials:NCT00594984]clinicaltrials:NCT00623766Phase II Study of Brivanib (BMS-582664) to Treat Multiple Tumor Types [clinicaltrials:NCT00633789]clinicaltrials:NCT00636168clinicaltrials:NCT00643201A Phase 1 Study of BMS-833923 (XL139) in Subjects With Advanced or Metastatic Cancer [clinicaltrials:NCT00670189]clinicaltrials:NCT00696072Multiple Ascending Dose (MDX1105-01) [clinicaltrials:NCT00729664]clinicaltrials:NCT00730639A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC [clinicaltrials:NCT00743938]clinicaltrials:NCT00744497Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor [clinicaltrials:NCT00754325]clinicaltrials:NCT00767520clinicaltrials:NCT00777036clinicaltrials:NCT00798252Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment [clinicaltrials:NCT00825955]Ph II of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Treatment of Non-Small Cell Lung Cancer [clinicaltrials:NCT00850577]clinicaltrials:NCT00858871Study of Immunotherapy to Treat Advanced Prostate Cancer [clinicaltrials:NCT00861614]clinicaltrials:NCT00883116
link [clinicaltrials_vocabulary:link]
BMS clinical trial educational resource [clinicaltrials_resource:ecfe78d31cdc78071484d9e34e103653]
Bio2RDF identifier
ecfe78d31cdc78071484d9e34e103653
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ecfe78d31cdc78071484d9e34e103653
url [clinicaltrials_vocabulary:url]
identifier
clinicaltrials_resource:ecfe78d31cdc78071484d9e34e103653
title
BMS clinical trial educational resource
@en
type
label
BMS clinical trial educational ...... e78d31cdc78071484d9e34e103653]
@en